ID   GYS2_RAT                Reviewed;         704 AA.
AC   P17625; Q99MF8;
DT   01-AUG-1990, integrated into UniProtKB/Swiss-Prot.
DT   16-DEC-2008, sequence version 2.
DT   02-OCT-2024, entry version 130.
DE   RecName: Full=Glycogen [starch] synthase, liver {ECO:0000305|PubMed:2110561};
DE            EC=2.4.1.11 {ECO:0000269|PubMed:1731614};
DE   AltName: Full=Glycogen synthase 2 {ECO:0000312|RGD:2773};
GN   Name=Gys2 {ECO:0000312|RGD:2773};
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Liver;
RX   PubMed=2110561; DOI=10.1016/s0021-9258(19)39007-6;
RA   Bai G., Zhang Z., Werner R., Nuttall F.Q., Tan A.W.H., Lee E.Y.C.;
RT   "The primary structure of rat liver glycogen synthase deduced by cDNA
RT   cloning. Absence of phosphorylation sites 1a and 1b.";
RL   J. Biol. Chem. 265:7843-7848(1990).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=Wistar; TISSUE=Liver;
RA   Ferrer J.C., Baque S., Guinovart J.J.;
RT   "Glucose-regulated localization of liver glycogen synthase at the
RT   hepatocyte periphery.";
RL   Submitted (FEB-2001) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   FUNCTION, CATALYTIC ACTIVITY, ACTIVITY REGULATION, BIOPHYSICOCHEMICAL
RP   PROPERTIES, PATHWAY, AND TISSUE SPECIFICITY.
RC   TISSUE=Liver;
RX   PubMed=1731614; DOI=10.1016/0003-9861(92)90019-s;
RA   Westphal S.A., Nuttall F.Q.;
RT   "Comparative characterization of human and rat liver glycogen synthase.";
RL   Arch. Biochem. Biophys. 292:479-486(1992).
RN   [4]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-8; SER-11 AND SER-627, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: Glycogen synthase participates in the glycogen biosynthetic
CC       process along with glycogenin and glycogen branching enzyme. Extends
CC       the primer composed of a few glucose units formed by glycogenin by
CC       adding new glucose units to it. In this context, glycogen synthase
CC       transfers the glycosyl residue from UDP-Glc to the non-reducing end of
CC       alpha-1,4-glucan. {ECO:0000269|PubMed:1731614}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=[(1->4)-alpha-D-glucosyl](n) + UDP-alpha-D-glucose = [(1->4)-
CC         alpha-D-glucosyl](n+1) + H(+) + UDP; Xref=Rhea:RHEA:18549, Rhea:RHEA-
CC         COMP:9584, Rhea:RHEA-COMP:9587, ChEBI:CHEBI:15378, ChEBI:CHEBI:15444,
CC         ChEBI:CHEBI:58223, ChEBI:CHEBI:58885; EC=2.4.1.11;
CC         Evidence={ECO:0000269|PubMed:1731614};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:18550;
CC         Evidence={ECO:0000269|PubMed:1731614};
CC   -!- ACTIVITY REGULATION: Allosteric activation by glucose-6-phosphate
CC       (PubMed:1731614). Phosphorylation reduces the activity towards UDP-
CC       glucose (PubMed:1731614). When in the non-phosphorylated state,
CC       glycogen synthase does not require glucose-6-phosphate as an allosteric
CC       activator; when phosphorylated it does (PubMed:1731614).
CC       {ECO:0000269|PubMed:1731614}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=1.4 mM for UDP-alpha-D-glucose (UDPG) (in the absence of glucose-
CC         6-phosphate) (poorly or non-phosphorylated state)
CC         {ECO:0000269|PubMed:1731614};
CC         KM=1.0 mM for UDP-alpha-D-glucose (UDPG) (in the presence of 50 uM
CC         glucose-6-phosphate) (poorly or non-phosphorylated state)
CC         {ECO:0000269|PubMed:1731614};
CC         KM=0.2 mM for UDP-alpha-D-glucose (UDPG) (in the presence of 7.2 mM
CC         glucose-6-phosphate) (poorly or non-phosphorylated state)
CC         {ECO:0000269|PubMed:1731614};
CC         KM=32.0 mM for UDP-alpha-D-glucose (UDPG) (in the absence of glucose-
CC         6-phosphate) (most phosphorylated state)
CC         {ECO:0000269|PubMed:1731614};
CC         KM=17 mM for UDP-alpha-D-glucose (UDPG) (in the presence of 70 uM of
CC         glucose-6-phosphate) (most phosphorylated state)
CC         {ECO:0000269|PubMed:1731614};
CC         KM=11.0 mM for UDP-alpha-D-glucose (UDPG) (in the presence of 200 uM
CC         of glucose-6-phosphate) (most phosphorylated state)
CC         {ECO:0000269|PubMed:1731614};
CC         KM=0.4 mM for UDP-alpha-D-glucose (UDPG) (in the presence of 7.2 mM
CC         glucose-6-phosphate) (most phosphorylated state)
CC         {ECO:0000269|PubMed:1731614};
CC       pH dependence:
CC         Optimum pH is 7.5-8.5 (at 25 degrees Celsius) (non-phosphorylated
CC         state). Optimum pH is 8.5 (at 25 degrees Celsius) (most
CC         phosphorylated state). {ECO:0000269|PubMed:1731614};
CC       Temperature dependence:
CC         Optimum temperature is 30-40 degrees Celsius.
CC         {ECO:0000269|PubMed:1731614};
CC   -!- PATHWAY: Glycan biosynthesis; glycogen biosynthesis.
CC       {ECO:0000269|PubMed:1731614}.
CC   -!- SUBUNIT: Part of the glycogen synthase (GS)-glycogenin complex, a
CC       heterooctamer composed of a tetramer of GS and 2 dimers of glycogenin,
CC       where each GS protomer binds to one glycogenin subunit (via glycogenin
CC       C-terminus); the GS tetramer may dissociate from glycogenin dimers to
CC       continue glycogen polymerization on its own (By similarity). May also
CC       form a heterooctamer complex with GYG1 (via GYG1 C-terminus) (By
CC       similarity). {ECO:0000250|UniProtKB:P13807,
CC       ECO:0000250|UniProtKB:Q8VCB3}.
CC   -!- TISSUE SPECIFICITY: Specifically expressed in liver (at protein level).
CC       {ECO:0000269|PubMed:1731614}.
CC   -!- PTM: Primed phosphorylation at Ser-657 (site 5) by CSNK2A1 and CSNK2A2
CC       is required for inhibitory phosphorylation at Ser-641 (site 3a), Ser-
CC       645 (site 3b), Ser-649 (site 3c) and Ser-653 (site 4) by GSK3A an
CC       GSK3B. Dephosphorylation at Ser-641 and Ser-645 by PP1 activates the
CC       enzyme (By similarity). Phosphorylation at Ser-8 is not required for
CC       interaction with GYG1 (By similarity). Interaction with GYG1 does not
CC       regulate the phosphorylation at Ser-8 and Ser-641 (By similarity).
CC       {ECO:0000250|UniProtKB:P13807, ECO:0000250|UniProtKB:P13834,
CC       ECO:0000250|UniProtKB:Q8VCB3}.
CC   -!- SIMILARITY: Belongs to the glycosyltransferase 3 family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; J05446; AAA41255.1; -; mRNA.
DR   EMBL; AF346902; AAK16592.1; -; mRNA.
DR   PIR; A35362; A35362.
DR   AlphaFoldDB; P17625; -.
DR   SMR; P17625; -.
DR   IntAct; P17625; 1.
DR   STRING; 10116.ENSRNOP00000074743; -.
DR   CAZy; GT3; Glycosyltransferase Family 3.
DR   iPTMnet; P17625; -.
DR   PhosphoSitePlus; P17625; -.
DR   PaxDb; 10116-ENSRNOP00000059573; -.
DR   UCSC; RGD:2773; rat.
DR   AGR; RGD:2773; -.
DR   RGD; 2773; Gys2.
DR   eggNOG; KOG3742; Eukaryota.
DR   InParanoid; P17625; -.
DR   PhylomeDB; P17625; -.
DR   UniPathway; UPA00164; -.
DR   PRO; PR:P17625; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0005938; C:cell cortex; IDA:UniProtKB.
DR   GO; GO:0030864; C:cortical actin cytoskeleton; IDA:UniProtKB.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005856; C:cytoskeleton; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IDA:UniProtKB.
DR   GO; GO:0005536; F:D-glucose binding; IDA:RGD.
DR   GO; GO:0004373; F:glycogen (starch) synthase activity; IDA:UniProtKB.
DR   GO; GO:0005978; P:glycogen biosynthetic process; IDA:UniProtKB.
DR   GO; GO:0005977; P:glycogen metabolic process; IDA:RGD.
DR   GO; GO:0009749; P:response to glucose; IDA:UniProtKB.
DR   CDD; cd03793; GT3_GSY2-like; 1.
DR   Gene3D; 3.40.50.2000; Glycogen Phosphorylase B; 2.
DR   InterPro; IPR008631; Glycogen_synth.
DR   PANTHER; PTHR10176:SF1; GLYCOGEN [STARCH] SYNTHASE, LIVER; 1.
DR   PANTHER; PTHR10176; GLYCOGEN SYNTHASE; 1.
DR   Pfam; PF05693; Glycogen_syn; 1.
DR   SUPFAM; SSF53756; UDP-Glycosyltransferase/glycogen phosphorylase; 2.
PE   1: Evidence at protein level;
KW   Allosteric enzyme; Glycogen biosynthesis; Glycosyltransferase;
KW   Phosphoprotein; Reference proteome; Transferase.
FT   CHAIN           1..704
FT                   /note="Glycogen [starch] synthase, liver"
FT                   /id="PRO_0000194769"
FT   REGION          620..704
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        659..673
FT                   /note="Acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        690..704
FT                   /note="Basic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         40
FT                   /ligand="UDP"
FT                   /ligand_id="ChEBI:CHEBI:58223"
FT                   /evidence="ECO:0000250|UniProtKB:P13807"
FT   BINDING         205
FT                   /ligand="UDP-alpha-D-glucose"
FT                   /ligand_id="ChEBI:CHEBI:58885"
FT                   /evidence="ECO:0000250|UniProtKB:P13807"
FT   BINDING         211
FT                   /ligand="UDP-alpha-D-glucose"
FT                   /ligand_id="ChEBI:CHEBI:58885"
FT                   /evidence="ECO:0000250|UniProtKB:P13807"
FT   BINDING         291
FT                   /ligand="alpha-D-glucose 6-phosphate"
FT                   /ligand_id="ChEBI:CHEBI:58225"
FT                   /ligand_note="allosteric activator; ligand shared between
FT                   two neighboring subunits"
FT                   /note="in other chain"
FT                   /evidence="ECO:0000250|UniProtKB:P13807"
FT   BINDING         292
FT                   /ligand="alpha-D-glucose 6-phosphate"
FT                   /ligand_id="ChEBI:CHEBI:58225"
FT                   /ligand_note="allosteric activator; ligand shared between
FT                   two neighboring subunits"
FT                   /note="in other chain"
FT                   /evidence="ECO:0000250|UniProtKB:P13807"
FT   BINDING         294
FT                   /ligand="alpha-D-glucose 6-phosphate"
FT                   /ligand_id="ChEBI:CHEBI:58225"
FT                   /ligand_note="allosteric activator; ligand shared between
FT                   two neighboring subunits"
FT                   /evidence="ECO:0000250|UniProtKB:P13807"
FT   BINDING         297
FT                   /ligand="alpha-D-glucose 6-phosphate"
FT                   /ligand_id="ChEBI:CHEBI:58225"
FT                   /ligand_note="allosteric activator; ligand shared between
FT                   two neighboring subunits"
FT                   /evidence="ECO:0000250|UniProtKB:P13807"
FT   BINDING         301
FT                   /ligand="alpha-D-glucose 6-phosphate"
FT                   /ligand_id="ChEBI:CHEBI:58225"
FT                   /ligand_note="allosteric activator; ligand shared between
FT                   two neighboring subunits"
FT                   /evidence="ECO:0000250|UniProtKB:P13807"
FT   BINDING         331
FT                   /ligand="UDP"
FT                   /ligand_id="ChEBI:CHEBI:58223"
FT                   /evidence="ECO:0000250|UniProtKB:P13807"
FT   BINDING         331
FT                   /ligand="UDP-alpha-D-glucose"
FT                   /ligand_id="ChEBI:CHEBI:58885"
FT                   /evidence="ECO:0000250|UniProtKB:P13807"
FT   BINDING         501
FT                   /ligand="alpha-D-glucose 6-phosphate"
FT                   /ligand_id="ChEBI:CHEBI:58225"
FT                   /ligand_note="allosteric activator; ligand shared between
FT                   two neighboring subunits"
FT                   /evidence="ECO:0000250|UniProtKB:P13807"
FT   BINDING         510
FT                   /ligand="UDP-alpha-D-glucose"
FT                   /ligand_id="ChEBI:CHEBI:58885"
FT                   /evidence="ECO:0000250|UniProtKB:P13807"
FT   BINDING         512
FT                   /ligand="UDP-alpha-D-glucose"
FT                   /ligand_id="ChEBI:CHEBI:58885"
FT                   /evidence="ECO:0000250|UniProtKB:P13807"
FT   BINDING         513
FT                   /ligand="UDP-alpha-D-glucose"
FT                   /ligand_id="ChEBI:CHEBI:58885"
FT                   /evidence="ECO:0000250|UniProtKB:P13807"
FT   BINDING         515
FT                   /ligand="UDP"
FT                   /ligand_id="ChEBI:CHEBI:58223"
FT                   /evidence="ECO:0000250|UniProtKB:P13807"
FT   BINDING         582
FT                   /ligand="alpha-D-glucose 6-phosphate"
FT                   /ligand_id="ChEBI:CHEBI:58225"
FT                   /ligand_note="allosteric activator; ligand shared between
FT                   two neighboring subunits"
FT                   /evidence="ECO:0000250|UniProtKB:P13807"
FT   BINDING         586
FT                   /ligand="alpha-D-glucose 6-phosphate"
FT                   /ligand_id="ChEBI:CHEBI:58225"
FT                   /ligand_note="allosteric activator; ligand shared between
FT                   two neighboring subunits"
FT                   /evidence="ECO:0000250|UniProtKB:P13807"
FT   MOD_RES         8
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         11
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         627
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         641
FT                   /note="Phosphoserine; by GSK3-alpha and GSK3-beta"
FT                   /evidence="ECO:0000250|UniProtKB:P13834"
FT   MOD_RES         645
FT                   /note="Phosphoserine; by GSK3-alpha and GSK3-beta"
FT                   /evidence="ECO:0000250|UniProtKB:P13834"
FT   MOD_RES         649
FT                   /note="Phosphoserine; by GSK3-alpha and GSK3-beta"
FT                   /evidence="ECO:0000250|UniProtKB:P13834"
FT   MOD_RES         653
FT                   /note="Phosphoserine; by GSK3-alpha and GSK3-beta"
FT                   /evidence="ECO:0000250|UniProtKB:P13834"
FT   MOD_RES         657
FT                   /note="Phosphoserine; by CK2"
FT                   /evidence="ECO:0000250|UniProtKB:P13834"
FT   MOD_RES         684
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P54840"
FT   CONFLICT        82
FT                   /note="E -> R (in Ref. 1; AAA41255)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        268
FT                   /note="H -> D (in Ref. 1; AAA41255)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        555..557
FT                   /note="RRF -> SV (in Ref. 1; AAA41255)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        622
FT                   /note="H -> Y (in Ref. 1; AAA41255)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   704 AA;  80734 MW;  926BD3057470A1D4 CRC64;
     MLRGRSLSVT SLGGLPAWEA ERLPVEDLLL FEVSWEVTNK VGGICTVIQS KAKTTANEWG
     ENYFLIGPYF EHNVKTQVEP CEPANDAVRK AVDAMNKHGC QVHFGRWLIE GSPYVVLFDI
     SSSVWNLDRW KGDFWEACGV GIPHDDREAN DMLIFGSLTA WFLKEVTDHA DGKHVIAQFH
     EWQAGTGLIL SRARKLPIAT IFTTHATLLG RYLCAANIDF YNQLDKFNID KEAGERQIYH
     RYCMERASVH CAHVFTTVSE ITAIEADHML KRKPDVVTPN GLNVKKFSAV HEFQNLHATY
     KARIQDFVRG HFYGHLDFDL EKTLFLFIAG RYEFSNKGAD IFLESLSRLN FLLRMHKSNV
     TVVVFFIMPA KTNNFNVETL KGQAVRKQLW DTVHCMKEKF GKKLYDGLLR GEIPDMNSIL
     DRDDLTIMKR AIFSTQRHSL PPVTTHNMID DSTDPILSTI RRIGLFNNRT DRVKVILHPE
     FLSSTSPLLP MDYEEFVRGC HLGVFPSYYE PWGYTPAECT VMGIPSVTTN LSGFGCFMQE
     HVADPTAYGI YIVDRRFRSP DDSCNQLTQF LYGFCKQSRR QRIIQRNRTE RLSDLLDWRY
     LGRYYQHARH LTLSRAFPDK FHLEPTSPPT TDGFKYPRPS SVPPSPSGSQ TSSPQSSDVE
     NEGDEDERYD EEEEAERDRL NIKSPFSLNH IPKGKKKLHG EYKN
//
